Spruce Biosciences, Inc. (SPRB) vs Yarrow Bioscience, Inc (YARW)

Spruce Biosciences, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Yarrow Bioscience, Inc is the larger, with a market value of $147.2M against $133.8M — 1.1× the size. Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −51.3%. Spruce Biosciences, Inc. has the higher net margin (0.00% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Spruce Biosciences, Inc. leads on 8 and Yarrow Bioscience, Inc on 7.

Valuation

Metric SPRB YARW Biotechnology median
P/E n/m n/m 10.60
P/S 23.04 27.77 9.40
P/B 1.35 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.88 118.48 9.02
Earnings yield (88.60%) (138.76%) (32.88%)
Free cash flow yield (37.80%) (127.91%) (23.13%)

Profitability

Metric SPRB YARW Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (105.98%) (61.40%) (51.96%)
Return on assets (82.38%) (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SPRB YARW Biotechnology median
Revenue growth (TTM) (51.32%) 1.26% 6.76%
EPS growth (last fiscal year) 47.59% 32.26% 29.88%
Revenue growth, 5-year CAGR — (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRB YARW Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 9.23 15.26 4.97
Net debt to EBITDA 1.34 0.95 1.01

Dividend

Metric SPRB YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric SPRB YARW Biotechnology median
Market cap 133.79m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack